BVS (Bioventus Inc.) Stock Financials & Earnings | Market Cap Arena

BVS (Bioventus Inc.) Stock Financials & Earnings | Market Cap Arena

BVSBioventus Inc.

Mkt Cap$593M

Healthcare·Medical - Devices·🇺🇸 United States·NASDAQ

Revenue (TTM)$568M

Net Income (TTM)$23M

EPS (TTM)$0.33

Free Cash Flow (TTM)$72M

Gross Margin68.1%

Op. Margin10.3%

Net Margin4.0%

FCF Margin12.7%

P/S Ratio (TTM)1.0x

P/E Ratio (TTM)26.1x

YoY Rev Growth-0.9%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$119M	$74M	-$92M
Q2 23	$137M	$89M	$7M
Q3 23	$121M	$79M	$2M
Q4 23	$135M	$86M	$1M
Q1 24	$129M	$88M	$5M
Q2 24	$151M	$104M	-$31M
Q3 24	$139M	$94M	$4M
Q4 24	$154M	$103M	$8M
Q1 25	$124M	$83M	$5M
Q2 25	$148M	$102M	$18M
Q3 25	$139M	$93M	$12M
Q4 25	$158M	$109M	$23M

Revenue Breakdown

Valuation

Quarter	P/S	P/E
Q1 23	1.2x	—
Q2 23	1.2x	—
Q3 23	1.2x	—
Q4 23	1.2x	—
Q1 24	1.1x	—
Q2 24	1.1x	—
Q3 24	1.1x	—
Q4 24	1.0x	—
Q1 25	1.0x	—
Q2 25	1.1x	—
Q3 25	1.1x	75.8x
Q4 25	1.0x	26.1x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	$2M	-$1M
Q2 23	$11M	$9M
Q3 23	-$8M	-$10M
Q4 23	$10M	$10M
Q1 24	-$6M	-$6M
Q2 24	$15M	$15M
Q3 24	$10M	$10M
Q4 24	$19M	$19M
Q1 25	-$19M	-$20M
Q2 25	$26M	$25M
Q3 25	$30M	$30M
Q4 25	$38M	$37M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$4M
Q2 23	$1M
Q3 23	$2M
Q4 23	$369K
Q1 24	$291K
Q2 24	$77K
Q3 24	$64K
Q4 24	$574K
Q1 25	$826K
Q2 25	$683K
Q3 25	$473K
Q4 25	$580K

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	+1.5%	+52.2%
Q2 23	-2.3%	-9.3%
Q3 23	-6.1%	-53.7%
Q4 23	+7.6%	-11.2%
Q1 24	+8.7%	-41.0%
Q2 24	+10.3%	+40.2%
Q3 24	+15.0%	+14.0%
Q4 24	+13.5%	+8.5%
Q1 25	-4.3%	-4.4%
Q2 25	-2.4%	-29.2%
Q3 25	-0.2%	-6.2%
Q4 25	+2.8%	-7.5%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$2M	1.6%
Q2 23	-$3M	-2.0%
Q3 23	$2M	1.5%
Q4 23	$0	0.0%
Q1 24	$3M	2.0%
Q2 24	$4M	2.4%
Q3 24	$2M	1.5%
Q4 24	$2M	1.1%
Q1 25	$2M	1.9%
Q2 25	$4M	2.5%
Q3 25	$0	0.0%
Q4 25	$3M	2.2%

OpEx Breakdown

Quarter	R&D	SG&A
Q1 23	$4M	$81M
Q2 23	$3M	$75M
Q3 23	$3M	$70M
Q4 23	$3M	$78M
Q1 24	$3M	$79M
Q2 24	$4M	$97M
Q3 24	$4M	$81M
Q4 24	$3M	$87M
Q1 25	$3M	$74M
Q2 25	$3M	$79M
Q3 25	$3M	$78M
Q4 25	$3M	$83M

Revenue Segments

Quarter	International Segment	U.S. Segment
Q1 24	$15M	$114M
Q2 24	$17M	$134M
Q3 24	$16M	$123M
Q4 24	$18M	$135M
Q1 25	$13M	$111M
Q2 25	$19M	$129M
Q3 25	$15M	$123M
Q4 25	$18M	$139M

Revenue by Geography

Quarter	Non-US	United States
Q3 23	$15M	$106M
Q1 24	$15M	$114M
Q2 24	$17M	$134M
Q3 24	$16M	$123M
Q4 24	$18M	$135M
Q1 25	$13M	$111M
Q2 25	$19M	$129M
Q3 25	$15M	$123M
Q4 25	$18M	$139M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$47M	$0	$47M
Q2 23	$29M	$0	$29M
Q3 23	$27M	$0	$27M
Q4 23	$37M	$0	$37M
Q1 24	$25M	$0	$25M
Q2 24	$32M	$0	$32M
Q3 24	$43M	$0	$43M
Q4 24	$42M	$0	$42M
Q1 25	$23M	$0	$23M
Q2 25	$33M	$0	$33M
Q3 25	$42M	$0	$42M
Q4 25	$51M	$0	$51M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	62M	+0.3%
Q2 23	63M	+0.7%
Q3 23	63M	+0.4%
Q4 23	63M	+0.3%
Q1 24	63M	+0.6%
Q2 24	64M	+1.1%
Q3 24	65M	+1.9%
Q4 24	65M	+0.3%
Q1 25	66M	+0.9%
Q2 25	69M	+3.8%
Q3 25	69M	+0.4%
Q4 25	69M	+0.1%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 14	—	—
FY 15	—	—
FY 16	—	—
FY 17	—	—
FY 18	—	—
FY 19	—	—
FY 20	$459K	700
FY 21	$359K	1K
FY 22	$457K	1K
FY 23	$528K	970
FY 24	$616K	930
FY 25	$611K	930